期刊文献+

Nestin和Ki67在卵巢上皮性癌组织中的表达及临床意义 被引量:3

Expression and clinical significance of Nestin and Ki67 in epithelial ovarian cancer
下载PDF
导出
摘要 目的 探讨Nestin及Ki67在卵巢上皮性癌组织中的表达及其与临床病理特征的关系.方法 对2007年1月~2009年1月邯郸市中心医院妇科60例卵巢癌患者及20例卵巢正常患者的病理资料进行回顾性分析,采用免疫组化SP法检测卵巢上皮性癌标本及正常组织中Nestin及Ki67的表达,分析并比较正常卵巢组织及不同病理类型、FIGO分期、残余肿瘤直径的卵巢组织中Nestin及Ki67的表达情况.结果 ①卵巢上皮性癌标本中Nestin和Ki67阳性表达率(38.5%、76.7%)明显高于正常卵巢组织(5.0%、15.0%),两者相比,差异均有统计学意义(均P<0.05).②组织分化程度高级别的卵巢癌组织中Nestin及Ki67阳性表达率明显高于低级别者(P< 0.05);FIGO分期越高、残余肿瘤直径越大,Nestin、Ki67阳性表达率越高(均P<0.05).③Nestin与Ki67在卵巢癌中的表达无明显相关性(r=0.176,P=0.13).结论 Nestin与Ki67的表达与卵巢癌的发生、发展有密切关系,对Nestin与Ki67的检测可用于判断卵巢上皮性肿瘤的恶性程度及其预后. Objective To investigate the expression of Nestin and Ki67 in epithelial ovarian cancer and the relationship between their expression and clinicopathologic characteristics. Methods pathological files of 60 patients with epithelial ovarian carcinoma and 20 patients with nomal ovarian tissues from January 2007 to January 2009 in Gynecology De- partment of Central Hospital of Handan City were retrospective analyzed, the Nestin and Ki67 were detected by im- munohistochemistry (SP method), the expression of Nestin and Ki67 in nomal ovarian and epithelial ovarian cancer tissues with different pathological pattern, FIGO stages and residual tumor size were analyzed and compared. Results Fhe positive expression rate of Nestin Ki67 in ovarian epithelial carcinomas (38.5%, 76.7%) were higher than those in nor mal ovarian tissues(5.0% , 15.0%), the differences were statistically significant(all P 〈 0.05). The positive expression of Nestin and Ki67 in epithelial ovarian cancer tissues with high differentiation degree was higher than those in with low differentiation degree (all P 〈 0.05). The higher FIGO stage and larger residual tumor size, the higher positive ex pression of Nestin and Ki67 in epithelial ovarian cancer tissues. There was no significant correlation between Nestin and Ki67 expression (r = 0.176, P = 0.13). Conclusion The expressions of Nestin and Ki67 are associated with the de velopment and progression of the ovarian epithelial neoplasm, the detection of Nestin and Ki67 may be helpful to esti mate the malignant degree and prognosis of the epithelial ovarian carcinoma.
出处 《中国医药导报》 CAS 2014年第5期24-27,共4页 China Medical Herald
关键词 卵巢癌 KI67 免疫组化 KI67 Ovarian cancer Nestin Ki67 Immunohistochemistry
  • 相关文献

参考文献16

  • 1Armstrong DK,White AJ,Weli SC. Farletuzumab(a monoclonal antibody against folate receptor alpha)in relapsed platinum-sensitive ovarian cancer[J].{H}Gynecologic Oncology,2013,(03):452-458.
  • 2丰有吉.妇产科学[M]北京:人民卫生出版社,2010344.
  • 3张鸣号,彭亮,曹军.显微图像分析法与人工计数法在免疫组化结果判读中的应用[J].宁夏医科大学学报,2009,31(2):261-262. 被引量:38
  • 4Jin X,Jin X,Jung JE. Cell surface Nestin is a biomarker for glioma stem cells[J].{H}Biochemical and Biophysical Research Communications,2013,(04):496-501.
  • 5Enache S,Arsene D,Iosif C. Nestin and caveolin-1 in the diagnosis of GISTs[J].{H}Romanian Journal of Morphology and Embryology,2012,(01):41-46.
  • 6Ohnuma A,Yoshida T,Takahashi N. Malignant Leydig cell tumor with spindle-shaped cells in a male CD-1 mouse[J].J Vet Med Sc,2010,(05):661-664.
  • 7Akiyama M,Matsuda Y,Ishiwata T. Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma[J].{H}Journal of Investigative Dermatology,2013,(05):1384-1387.
  • 8许亮,董军,兰青.干细胞标志物CD133和Nestin在不同恶性程度胶质瘤组织中的表达及其与预后的关系[J].中国神经肿瘤杂志,2009,7(3):175-179. 被引量:8
  • 9Yerushalmi R,Woods R,Ravdin PM. Ki67 in breast cancer:prognostic and predictive potential[J].{H}LANCET ONCOLOGY,2010,(02):174-183.
  • 10常丽琴,吴素慧,李超,韩妍.Ki67、Survivin在早期宫颈癌中的表达与预后相关性分析[J].中国医药科学,2013,3(7):20-22. 被引量:8

二级参考文献51

共引文献65

同被引文献39

  • 1郝永楠,赵伟佳.Nestin的研究进展[J].广西医科大学学报,2007,24(4):650-652. 被引量:5
  • 2Donizy P,Rudno-Rudzinska J,Halon A,et al.Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer-ROC curve analysis to find cut-off point[J].Anticancer Research,2014,34(6):3113-3118.
  • 3Chen G,Rong M,Luo D.TNFRSF6B neutralization antibody inhibits proliferation and induces apoptosis in hepatocellular carcinoma cell[J].Pathology,Research and Practice,2010,206(9):631-641.
  • 4Huang S,Chen G,Dang Y,et al.Overexpression of DcR3 and its significance on tumor cell differentiation and proliferation in glioma[J].PloS One,2014,9 (3):605236.
  • 5Yang M,Chen G,Dang Y,et al.Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients[J].Upsala Journal of Medical Sciences,2010,115(4):232-237.
  • 6Yamana K,Bilim V,Hara N,et al.Prognostic impact of FAS/CD95/APO-1 in urothelial cancers:decreased expression of Fas is associated with disease progression[J].British Journal of Cancer,2005,93(5):544-551.
  • 7Wu Q,Zheng Y,Chen D,et al.Aberrant expression of decoy receptor 3 in human breast cancer:relevance to lymphangiogenesis[J].The Journal of Surgical Research,2014,188(2):459-465.
  • 8Zhou J,Song S,Li D,et al.Decoy receptor 3(DcR3)overexpression predicts the prognosis and pN2 in pancreatic head carcinoma[J].World Journal of Surgical Oncology,2014,12:52.
  • 9Al-Sukhun S,Hussain M.Current understanding of the biology of advanced bladder cancer[J].Cancer,2003,7(8Suppl):2064-2075.
  • 10Abat D,Demirhan O,Inandiklioglu N,et al.Genetic alterations of chromosomes,p53 and p16 genes in low-and high-grade bladder cancer[J].Oncology Letters,2014,8(1):25-32.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部